Compare
Indivior vs Merck & (INDV vs MRK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Indivior (INDV) returned +24.6% and Merck & (MRK) +73.9%; so far this year the figures are +1.1% and +39.4%.
Merck & is the larger company by market value, about 84.5 times the size of Indivior.
On trailing earnings, INDV trades at 10.1 times and MRK at 149.7 times.
Revenue grew +16.3% at INDV and +4.9% at MRK over the last year.
INDV pays no dividend. MRK yields 2.32%.
Data as of the latest close. Not investment advice.
Relative performance
| INDV | MRK | |
|---|---|---|
| Price | $36.28 | $146.73 |
| 1-day | +2.57% | -0.14% |
| YTD | +1.11% | +39.40% |
| 1 year | +24.55% | +73.87% |
| 3 years | +83.23% | +42.66% |
| Market cap | $4.3B | $361.7B |
| P/E | 10.1 | 149.7 |
| P/S | 3.12 | 5.37 |
| P/B | — | 8.06 |
| Revenue growth | +16.30% | +4.90% |
| EPS growth | +254.50% | -87.10% |
| Gross margin % | 85.0 | 71.8 |
| Net margin % | 32.8 | 3.6 |
| ROE % | — | 5.5 |
| Debt / equity | — | 1.20 |
| FCF yield % | 0.7 | 4.1 |
| Dividend yield % | — | 2.32 |
| Beta | 0.63 | 0.18 |
| RSI (14) | 58.4 | 51.3 |
| Technical rating |